Tarceva and Capecitabine for Pancreatic Cancer

This study has been completed.
Sponsor:
Collaborators:
Genentech
Roche Global Development
Brigham and Women's Hospital
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Information provided by:
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00125021
First received: July 27, 2005
Last updated: October 30, 2009
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2008
  Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)